Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The primary outcome was the incremental cost-effectiveness ratio (ICER), defined as cost per QALY gained, with the willingness-to-pay threshold set at AU$28,000 per QALY [15]
Many of these effects are still under investigation in clinical studies and laboratories, and will likely be more clearly demonstrated in the near future
Some providers step patients down to a lower maintenance dose
GLP-1 diabetes and weight-loss drug side effects (Ozempic Face and more)
US$ 26.85
US$ 28.96
US$ 24.04
US$ 25.85
US$ 28.69
US$ 28.00
US$ 21.29
